Calls to expand vaccine portfolio

Original article by Natasha Robinson
The Australian – Page: 4 : 25-Jan-21

Australians are likely to be to access three probable COVID-19 vaccines over the coming 12 months, but the Moderna vaccine is currently not one of them. It and the Pfizer vaccine, which five millions Australia are due to receive, have shown the highest efficacy in clinical trials, but Australia has not been able to come to an agreement with Moderna over the supply of its vaccine. Epidemiologist Zoe Hyde says Australia should seriously consider using the Moderna vaccine in preference to the Oxford/Astra-Zeneca vaccine; Hyde says the Moderna vaccine will better prevent disease and is more likely to deliver herd immunity, which she contends should be Australia’s aim.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s